Intracellular activity and in vivo efficacy in a mouse model of septic arthritis of the novel pseudopeptide Pep16 against Staphylococcus aureus clinical isolates.
Jean-Baptiste MascaryValérie BordeauIrène NicolasMarie-Clémence VerdierPierre RocheteauVincent CattoirPublished in: JAC-antimicrobial resistance (2024)
, particularly owing to its robust intracellular activity.